Abstract: An assembly for mounting an umbrella proximate a mounting location for a ski pylon comprises an elongated member having a first end and an opposite second end. The first end defines features for securing the member first end to a ski pylon mount. The second end defining features for securing the member second end to a central shaft of an umbrella.

Abstract: An assembly for mounting an umbrella proximate a mounting location for a ski pylon comprises an elongated member having a first end and an opposite second end. The first end defines features for securing the member first end to a ski pylon mount. The second end defining features for securing the member second end to a central shaft of an umbrella.

Abstract: A foldable electric cable having a core with conductors and a sheath; where in the sheath consists of rigid and soft sections so that the electric cable is capable of being folded. A method for the manufacturing of the foldable electric cable through the use of an alternate polymer extrusion system; whereby the rigid and soft polymer materials are deposited around the core of conductors.

Abstract: A magnetic recording tape includes an elongated substrate and a magnetic side. The magnetic side includes a support layer formed over the substrate and a magnetic recording layer formed over the support layer to define a magnetic recording surface opposite the substrate. The magnetic recording layer includes magnetic particles and a lubricant and supports a net uncompressed density of at least 30 MB/in2. The magnetic side has an extracted BET surface area of greater than 1.0 m2/g.

Abstract: Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines.

Abstract: The present invention relates to a vaccine for immunizing a cat against feline viruses. The present invention also relates to a nucleic acid clone that encodes the capsid protein of the isolated feline calicivirus. The present invention further relates to a live or killed vaccine comprising the isolated feline calicivirus, a subunit vaccine comprising the capsid protein of the isolated feline calicivirus, a nucleic acid vaccine comprising a nucleic acid clone of the isolated feline calicivirus, and a recombinant virus vector vaccine comprising nucleic acid encoding the capsid protein of the isolated feline calicivirus. The present invention also relates to a method for identifying a feline calicivirus useful for producing a vaccine composition and for assays for diagnosing cats infected with feline calicivirus. Also disclosed is a method of immunizing animals, especially cats, against disease, in particular against feline calicivirus (FCV).

Abstract: The present invention provides Drosophila melanogaster GPCR (DmGPCR) polypeptides and polynucleotides which identify and encode such a DmGPCR. In addition, the invention provides expression vectors, host cells, and methods for its production. The invention also provides methods for the identification of homologues in other species and of DmGPCR agonists/antagonists useful as potential insecticides. The invention further provides methods for binding a DmGPCR, methods for identifying modulators of DmGPCR expression and activity, methods for controlling a population of insects with a DmGPCR antibody, a DmGPCR antisense polynucleotide, a DmGPCR binding partner or modulator, and methods of preventing or treating a disease or condition associated with an ectoparasite. Specifically, this invention discloses the matching of the orphan Drosophila short neuropeptide F receptor with its cognate peptide ligands.

Abstract: A method for producing a magnetic recording medium includes applying a non-magnetic back coat to a substrate, applying a magnetic front coat to the substrate, in-line calendering the coated substrate using opposed rolls, at least one of the rolls being a generally compliant roll, and off-line calendering the substrate using opposed, generally non-compliant rolls. The off-line calendering optionally includes steel-on-steel calendering and the method optionally includes only one off-line calendering pass and only one in-line calendering pass. Calendering the coated substrate optionally occurs using at least one nip, the calendering including calendering the coated substrate through a final nip including generally non-compliant rolls. Other methods, and magnetic recording media produced by such methods, also are disclosed.

Abstract: Aspects of the present invention relate to an inkjet printable optical recording medium for sale to consumers. The optical medium includes an optical recording media and an inkjet receptive laminate. The optical recording media includes at least a transparent base material. The inkjet receptive laminate is bonded to the optical media and provides an inkjet receptive surface. With this in mind, the inkjet receptive laminate is characterized as exhibiting a Waterfast Optical Density Loss Percent Value of not more than 10%. In other embodiments, the Waterfast Optical Density Loss Percent Value is not less than 5%. In other embodiments, the inkjet receptive surface has a Dmin Value of not more than 0.10, a Brightness Value of at least 90%, and/or a BFR Value of not more than 16.

Abstract: Attenuated mutant Salmonella bacteria containing inactivated virulence genes are provided for use in safe efficacious vaccines.

Abstract: The invention provides neuropeptide ligands, G protein-coupled receptors and methods of screening for modulators of receptor activity. Identified modulators, including neuropeptide ligand mimetics, are useful as biostatic and biocidal agents of varying scope, ranging from lethal activity restricted to particular invertebrate parasites to broad spectrum invertebrate parasiticides active on a wide range of invertebrates, including helminths and insects.

Abstract: Attenuated mutant Salmonella bacteria containing inactivated virulence genes are provided for use in vaccines.

Abstract: Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of novel gram negative bacterial mutants useful in vaccines.